clinafloxacin has been researched along with Respiratory Tract Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rossi, C; Sternon, J | 1 |
| Shah, P; Tack, K; Trostmann, U | 1 |
1 review(s) available for clinafloxacin and Respiratory Tract Infections
| Article | Year |
|---|---|
[Third and fourth generation fluoroquinolones].
Topics: Administration, Oral; Anti-Infective Agents; Aza Compounds; Belgium; Biological Availability; Drug Monitoring; Drug Resistance; Fluoroquinolones; Gemifloxacin; Humans; Intestinal Absorption; Levofloxacin; Moxifloxacin; Naphthyridines; Ofloxacin; Patient Selection; Pneumococcal Infections; Quinolines; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors; Treatment Outcome | 2001 |
1 trial(s) available for clinafloxacin and Respiratory Tract Infections
| Article | Year |
|---|---|
Open-label, multicentre, emergency-use study of clinafloxacin (CI-960) in the treatment of patients with serious life-threatening infections.
Topics: Adult; Anti-Infective Agents; Bacterial Infections; Critical Illness; Cross Infection; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gastrointestinal Diseases; Humans; Male; Middle Aged; Respiratory Tract Infections; Treatment Failure | 2002 |